VI
ABBV icon

VectorGlobal IAG’s AbbVie ABBV Stock Holding History

VectorGlobal IAG’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9M Buy
+49,953
New +$11.1M 2.82% 11

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VectorGlobal IAG's ABBV Position: Q1 2026 in Review

VectorGlobal IAG opened a new position in AbbVie (ABBV) in Q1 2026: 49,953 shares worth $10.9M. The stake represents 2.82% of the portfolio and ranks #11 among its holdings.

4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • VectorGlobal IAG held 49,953 shares of AbbVie worth $10.9M as of Q1 2026.
  • AbbVie was a new VectorGlobal IAG position in Q1 2026.
  • AbbVie made up 2.82% of VectorGlobal IAG's portfolio in Q1 2026, its #11 holding.
  • 4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on VectorGlobal IAG's 13F filing for Q1 2026, filed 30 Jun 2026.